John B. Mowell
Chairman of the Board and Executive Director
John is president and CEO of Mowell Financial Group of Tallahassee, Florida, an investment-banking firm he founded in 1980 serving clients primarily throughout the Southeast. Since 2007, he has served as chairman of the board for Entegrion and added the duties of executive director in 2011. He is a founder and executive director of Beartooth Energy, a developer of oil and gas resources. He also served since 1984 on the board and as chairman since 2002 of EMS Technologies, a publicly traded, leading innovator in the design and manufacture of wireless, satellite and defense solutions; he sold the company to Honeywell in 2011. Among his many public service roles, he was appointed by the governor to the Florida State Board of Administration, the agency responsible for the management of over $70 billion of state retirement assets, where he served two terms as chairman. He also served on the board and executive committee of Capital City Bank in Tallahassee, one of the oldest banks in Florida. He earned his bachelor of science in economics from the University of Pennsylvania and is a graduate of the Wharton School of Commerce and Finance. He also served in the military as a naval aviator engaged in carrier-based anti-submarine warfare operations in the North Atlantic.
Executive Vice President, Secretary, and Treasurer
Martin brings over 30 years of public and private company financial and operations experience to Entegrion. His career includes serving financial services and healthcare clients as an auditor and consultant at KPMG and Ernst & Young, and substantial experience financing and operating healthcare services companies and early-stage life science companies. Martin’s community involvement includes his role as a director and Treasurer of The Kramden Institute, and as Chairman of the Corporate Advisory Counsel of the Carolina’s Chapter of the Cystic Fibrosis Foundation. Martin holds a master’s degree in accounting from Virginia Tech and is a certified public accountant licensed in North Carolina.
Vice President, Operations
Galiger has experience in both the medical device and biotech industries. He has a successful track record in New Product Development, Manufacturing start-up and Technology Transfer and he is co-inventor of the Resusix technology. Prior to Entegrion he served as the Director of New Product Development and Strategic Sourcing at Charter Medical and a a Technology Transfer Engineer at Depuy-Mitek. He holds both an accounting degree from Kennesaw State University and an engineering degree from Georgia Tech.
Vice President, Chief Financial Officer
Reyer brings extensive accounting experience to Entegrion. She started her career at Ernst & Young, and worked with several large manufacturing companies before moving on to provide accounting assistance for numerous early-stage development companies. She ran a thriving consulting business before coming to Entegrion full-time. Reyer has a degree in accounting from Pennsylvania State University and is a certified public accountant licensed in North Carolina.
CMC and Regulatory Compliance Manager
Sullivan has more than 15 years of product development experience in generic over-the-counter medications, prescription oral drugs, and topical dermatology prescription products. She has taken more than 20 new products from inception to launch, working primarily in CMC and regulatory operations roles. She holds a bachelors degree from Purdue University in Pharmaceutical Science and a Masters in Pharmaceutics from the University of Cincinnati.
Patel brings years of quality and regulatory experience in FDA regulated industry to Entegrion. She developed and managed quality system procedures and compiled regulatory submissions for Class 2 medical devices at a surgical robotics company, while ensuring the quality and conformity of incoming materials. She holds a master's degree in chemistry and bachelor's degrees in chemistry and biology from East Carolina University.
Stacy Nelson, RAC
Director of Clinical Operations
Nelson brings expertise in managing multidisciplinary projects involving Phase 1-3 clinical trials, IND and NDA submissions, post-marketing pharmacovigilance and Chemistry, Manufacturing and Controls (CMC) according to GCP, GMP and ICH regulations. She has direct experience in the initiation and management of over 20 Phase 1 and Phase 2 multicenter trials. She earned her BS from the University of North Carolina at Chapel Hill.
Joseph A. Dacorta, MHA
Vice President, Chief Technology Officer
DaCorta has more than 30 years of healthcare experience in operational and tactical medicine, bio-defense and homeland security. He is a retired Navy Medical Service Corps officer with broad experience in federal acquisition of biomedical science and technology. He brings experience in biomedical research strategic planning, accessing federal funding, global commercialization and formation of public and private partnerships. DaCorta received his undergraduate from Southern Illinois University and his MHA from Baylor University.
Dr. Phillip C. Spinella, MD FCCM
Chief Clinical Consultant
Dr. Spinella is the Director of the Critical Care Translational Research Program in the Division of Critical Care, Department of Pediatrics at Washington University School of Medicine in St Louis. Dr. Spinella leads two large international research networks; the pediatric critical care blood research network, Blood Net, and the Trauma Hemostasis and Oxygenation Research Network. Spinella retired from the US Army as a Lt. Col. He was awarded Bronze Star and a Combat Medic Badge.Virginia Tech and is a certified public accountant licensed in North Carolina.